RK-582
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RK-582, covering 2025-07-29 to 2025-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal Cancer [Phase 1]